ADHD drug data to be reviewed

Published: Sept. 17, 2007 at 11:54 AM

WASHINGTON, Sept. 17 (UPI) -- Two U.S. Department of Health and Human Services agencies announced Monday they will collaborate in a review of ADHD drugs.

Officials at the Food and Drug Administration and the Agency for Healthcare Research and Quality said they will conduct the most comprehensive study to date of prescription medications used to treat attention deficit hyperactivity disorder to determine the drugs' potential for increased risk of heart attack, stroke or other cardiovascular problems.

The review will include the clinical data of about 500,000 children and adults who have taken medications used to treat ADHD.

The two-year study will be coordinated by Vanderbilt University. Data analysis will be performed by researchers at Vanderbilt, Kaiser Permanente of California, the HMO Research Network and i3 Drug Safety, an Ingenix company.

© 2007 United Press International, Inc. All Rights Reserved.
Order reprints



Additional News Stories
Northern Rock shareholders stiffed (3 min)
Pacers' Granger out 4-6 weeks (14 min)
Accounting board chair recommends changes (22 min)
Alabama's McClain wins Butkus Award (25 min)
Snow crystal water determines shape (51 min)
Low emissions diesel truck engine created (53 min)
Woods' mother-in-law hospitalized (57 min)
fark
The "best" of the um, aughts? (sponsored link)
100-year-old says you're only as old as the kiddies you feel
Swedish group wants change hymen to "vaginal corona." Won't the lime sting?
Taking advantage of a city gripped by football fever, thieves launch daring $6m raid. Somebody should...
Photoshop theme: unneeded movie sequels
Asking your dad if he has an old hat to donate to your school's fundraising auction works a little...